Sun Pharmaceutical Industries is currently trading at Rs. 519.60, up by 8.95 points or 1.75% from its previous closing of Rs. 510.65 on the BSE.
The scrip opened at Rs. 516.65 and has touched a high and low of Rs. 521.20 and Rs. 516.65 respectively. So far 29264 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 434.80 on 22-May-2018.
Last one week high and low of the scrip stood at Rs. 535.00 and Rs. 507.20 respectively. The current market cap of the company is Rs. 122521.70 crore.
The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 33.31% and 12.31% respectively.
Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Global FZE -- has agreed to acquire 100% shares of Pola Pharma Inc., Japan, subject to completion of closing conditions, by way of cash consideration of 100 million Japanese Yen (around $1 million). This acquisition would give commercial presence in the dermatology segment in Japan.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |